StockData
InspireMD, Inc. logo

InspireMD, Inc. (NSPR) stock

NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3050% below fair value
$0.69+0.04 (+5.48%)

Close on Nov 18, 2026Market cap $31.87MP/E –Yield –

InspireMD free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

InspireMD's free cash flow for the twelve months ending Jun 30, 2026 was -$42.46M. For fiscal 2025 it was -$36.77M. The highest annual figure on record is -$1.58M in fiscal 2009.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$36.77M–
FY2024Dec 31, 2024-$23.27M–
FY2023Dec 31, 2023-$16.76M–
FY2022Dec 31, 2022-$16.02M–
FY2021Dec 31, 2021-$13.55M–
FY2020Dec 31, 2020-$9.17M–
FY2019Dec 31, 2019-$10.09M–
FY2018Dec 31, 2018-$7.67M–
FY2017Dec 31, 2017-$8.39M–
FY2016Dec 31, 2016-$7.54M–
FY2015Dec 31, 2015-$11.61M–
FY2013Jun 30, 2013-$10.50M–
FY2010Dec 31, 2010-$2.79M–
FY2009Dec 31, 2009-$1.58M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$11.23M–
Q1 FY2026Mar 31, 2026-$12.53M–
Q4 FY2025Dec 31, 2025-$9.74M–
Q3 FY2025Sep 30, 2025-$8.96M–
Q2 FY2025Jun 30, 2025-$8.91M–
Q1 FY2025Mar 31, 2025-$9.15M–
Q4 FY2024Dec 31, 2024-$7.06M–
Q3 FY2024Sep 30, 2024-$6.12M–
Q2 FY2024Jun 30, 2024-$4.83M–
Q1 FY2024Mar 31, 2024-$5.26M–
Q4 FY2023Dec 31, 2023-$4.39M–
Q3 FY2023Sep 30, 2023-$4.14M–
Q2 FY2023Jun 30, 2023-$3.37M–
Q1 FY2023Mar 31, 2023-$4.86M–
Q4 FY2022Dec 31, 2022-$3.29M–
Q3 FY2022Sep 30, 2022-$5.33M–
Q2 FY2022Jun 30, 2022-$3.22M–
Q1 FY2022Mar 31, 2022-$4.17M–
Q4 FY2021Dec 31, 2021-$3.01M–
Q3 FY2021Sep 30, 2021-$4.30M–
Q2 FY2021Jun 30, 2021-$2.58M–
Q1 FY2021Mar 31, 2021-$3.67M–
Q4 FY2020Dec 31, 2020-$2.26M–
Q4 FY2019Dec 31, 2019-$1.62M–
Q3 FY2019Sep 30, 2019-$1.93M–
Q2 FY2019Jun 30, 2019-$3.00M–
Q1 FY2019Mar 31, 2019-$3.55M–
Q4 FY2018Dec 31, 2018-$1.84M–
Q3 FY2018Sep 30, 2018-$1.83M–
Q2 FY2018Jun 30, 2018-$2.22M–
Q1 FY2018Mar 31, 2018-$1.78M–
Q4 FY2017Dec 31, 2017-$1.80M–
Q3 FY2017Sep 30, 2017-$2.08M–
Q2 FY2017Jun 30, 2017-$1.60M–
Q1 FY2017Mar 31, 2017-$2.91M–
Q4 FY2016Dec 31, 2016-$1.92M–
Q3 FY2016Sep 30, 2016-$2.96M–

More InspireMD figures

See a number that looks wrong?